Projects per year
Search results
-
Active
Increasing access to cancer trials in Minnesota (InACT-MN)
Erickson, B. K., Geller, M. A., Greeno, E. W., Kratzke, R. A., Ondrey, F. G., Teoh, D. G. & Yee, D.
NIH NATIONAL CANCER INSTITUTE (NCI)
9/18/23 → 8/31/28
Project: Research project
-
Treatment of Stage I-III Squamous Cell Carcinoma (SCC) of the Anal Canal
Butler, M. E., Arsoniadis, E. G., Church, T. R., Ester, E. C., Goffredo, P., Greeno, E. W., Lamina, T., Southwell, B. J., Sultan, S. & Wilt, T. J.
U.S. DEPT OF HEALTH & HUMAN SERV AHRQ
3/27/23 → 4/16/24
Project: Research project
-
Stromal re-engineering to promote responsiveness to checkpoint blockade
Provenzano, P. & Greeno, E. W.
2/1/22 → 7/31/24
Project: Research project
-
Finished
-
Phase 1-2 Study of ADI-PEG 20 plus FOLFOX in Subjects withAdvanced Gastrointestinal Malignancies
12/1/17 → 11/30/22
Project: Research project
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
A randomized, double blind, placebo-controlled, multicen
BAYER HEALTHCARE PHARMACEUTICALS
2/28/13 → 2/25/18
Project: Research project
-
-
-
Phase 2 Placebo-controlled Double blind Trial of Dasatin
OTSUKA PHARMACEUTICAL DEV. & COMM., INC.
2/17/11 → 7/30/15
Project: Research project
-
A Randomized Phase III, Double-Blind, Placebo-Controlled
NOVARTIS PHARMACEUTICALS CORPORATION
7/24/10 → 3/1/13
Project: Research project
-
-
A Phase III Randomized, Placebo Controlled, Double Blind
BAYER HEALTHCARE PHARMACEUTICALS
10/13/09 → 10/31/15
Project: Research project
-
A Randomized, Double-Blind, Multi-Center Phase III Study
Greeno, E. W. & Gada, P.
NOVARTIS PHARMACEUTICALS CORPORATION
6/23/09 → 12/31/12
Project: Research project
-
-
-
A Randomized, Open Label Multi-Center Study of Single Ag
10/31/08 → 12/31/10
Project: Research project
-
A Double-blinded, Randomized, Placebo-Controlled Phase I
Greeno, E. W. & Dudek, A. Z.
7/31/08 → 7/31/13
Project: Research project
-
-
A Phase III Randomized, double blind, pacebo-controlled
BAYER HEALTHCARE PHARMACEUTICALS
5/20/08 → 9/30/14
Project: Research project
-
A Phase 2 Evaluation of the Monoclonal Antibody RAV12, i
TGEN DRUG DEV SVC (TD2), RAVEN BIOTECHNOLOGIES INC
9/3/07 → 10/15/08
Project: Research project
-
Phase 2, Multicenter, Open-Label Study of CS-1008, A Hum
Vickers, S. & Greeno, E. W.
ICON CLINICAL RESEARCH, INC, SANKYO CO LTD
8/14/07 → 8/31/10
Project: Research project
-
-
CPTK787/ZK 222584 Colorectal Cancer
NOVARTIS PHARMACEUTICALS CORPORATION
1/1/03 → 9/30/06
Project: Research project
-
-
SURFACE REGULATION OF TISSUE FACTOR ACTIVITY
National Heart, Lung, and Blood Institute
7/1/93 → 6/30/94
Project: Research project